1. Home
  2. CPRX vs CATY Comparison

CPRX vs CATY Comparison

Compare CPRX & CATY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • CATY
  • Stock Information
  • Founded
  • CPRX 2002
  • CATY 1962
  • Country
  • CPRX United States
  • CATY United States
  • Employees
  • CPRX N/A
  • CATY N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • CATY Major Banks
  • Sector
  • CPRX Health Care
  • CATY Finance
  • Exchange
  • CPRX Nasdaq
  • CATY Nasdaq
  • Market Cap
  • CPRX 2.9B
  • CATY 3.3B
  • IPO Year
  • CPRX 2006
  • CATY N/A
  • Fundamental
  • Price
  • CPRX $20.78
  • CATY $47.20
  • Analyst Decision
  • CPRX Strong Buy
  • CATY Hold
  • Analyst Count
  • CPRX 6
  • CATY 5
  • Target Price
  • CPRX $32.83
  • CATY $49.80
  • AVG Volume (30 Days)
  • CPRX 1.4M
  • CATY 486.1K
  • Earning Date
  • CPRX 08-06-2025
  • CATY 07-22-2025
  • Dividend Yield
  • CPRX N/A
  • CATY 2.88%
  • EPS Growth
  • CPRX 178.13
  • CATY N/A
  • EPS
  • CPRX 1.57
  • CATY 3.95
  • Revenue
  • CPRX $534,645,999.00
  • CATY $691,279,000.00
  • Revenue This Year
  • CPRX $16.37
  • CATY $17.30
  • Revenue Next Year
  • CPRX $8.80
  • CATY $7.01
  • P/E Ratio
  • CPRX $13.34
  • CATY $11.94
  • Revenue Growth
  • CPRX 29.97
  • CATY N/A
  • 52 Week Low
  • CPRX $15.34
  • CATY $36.06
  • 52 Week High
  • CPRX $26.58
  • CATY $55.29
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 38.36
  • CATY 56.51
  • Support Level
  • CPRX $20.62
  • CATY $47.60
  • Resistance Level
  • CPRX $22.10
  • CATY $48.84
  • Average True Range (ATR)
  • CPRX 0.60
  • CATY 1.07
  • MACD
  • CPRX 0.06
  • CATY 0.12
  • Stochastic Oscillator
  • CPRX 50.34
  • CATY 56.19

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

Share on Social Networks: